REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 28th, 2020 • Miragen Therapeutics, Inc. • Services-medical laboratories
This Registration Rights Agreement (this “Agreement”) is dated as of October 30, 2020, by and among Miragen Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AGREEMENT AND PLAN OF MERGER among: MIRAGEN THERAPEUTICS, INC., a Delaware corporation; OCULUS MERGER SUB I, INC., a Delaware corporation; OCULUS MERGER SUB II, LLC, a Delaware limited liability company; and VIRIDIAN THERAPEUTICS, INC., a Delaware...Agreement and Plan of Merger • October 28th, 2020 • Miragen Therapeutics, Inc. • Services-medical laboratories • Delaware
THIS AGREEMENT AND PLAN OF MERGER is made and entered into as of October 27, 2020, by and among MIRAGEN THERAPEUTICS, INC., a Delaware corporation (“Parent”), OCULUS MERGER SUB I, INC., a Delaware corporation and wholly owned subsidiary of Parent (“First Merger Sub”), OCULUS MERGER SUB II, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (“Second Merger Sub” and together with First Merger Sub, “Merger Subs”), and VIRIDIAN THERAPEUTICS, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 28th, 2020 • Miragen Therapeutics, Inc. • Services-medical laboratories • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October 27, 2020, by and among MIRAGEN THERAPEUTICS, INC., a Delaware corporation (the “Company”), and each purchaser identified on Annex A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
